242 related articles for article (PubMed ID: 28082233)
1. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis.
Malekzadeh A; Twaalfhoven H; Wijnstok NJ; Killestein J; Blankenstein MA; Teunissen CE
Cytokine; 2017 Mar; 91():145-152. PubMed ID: 28082233
[TBL] [Abstract][Full Text] [Related]
2. How to: Measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays.
Belzeaux R; Lefebvre MN; Lazzari A; Le Carpentier T; Consoloni JL; Zendjidjian X; Abbar M; Courtet P; Naudin J; Boucraut J; Gressens P; Glaichenhaus N; Ibrahim EC
Psychoneuroendocrinology; 2017 Jan; 75():72-82. PubMed ID: 27810706
[TBL] [Abstract][Full Text] [Related]
3. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
[TBL] [Abstract][Full Text] [Related]
4. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
5. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
Ludwig MD; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
[TBL] [Abstract][Full Text] [Related]
6. Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Kallaur AP; Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Lopes J; de Carvalho Jennings Pereira WL; de Meleck Proença C; Borelli SD; Kaimen-Maciel DR; Maes M; Reiche EMV
Mol Neurobiol; 2017 May; 54(4):2950-2960. PubMed ID: 27023227
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms.
Bender DE; Schaettler MO; Sheehan KC; Johanns TM; Dunn GP
Biomark Insights; 2021; 16():11772719211006666. PubMed ID: 33854293
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Bead-Based Fluorescence Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human Plasma.
Günther A; Becker M; Göpfert J; Joos T; Schneiderhan-Marra N
Front Immunol; 2020; 11():572634. PubMed ID: 33101295
[TBL] [Abstract][Full Text] [Related]
10. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
Maimone D; Gregory S; Arnason BG; Reder AT
J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
[TBL] [Abstract][Full Text] [Related]
11. Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro.
Codorean E; Nichita C; Albulescu L; Răducan E; Popescu ID; Lonită AC; Albulescu R
Roum Arch Microbiol Immunol; 2010; 69(1):13-9. PubMed ID: 21053779
[TBL] [Abstract][Full Text] [Related]
12. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling.
Chowdhury F; Williams A; Johnson P
J Immunol Methods; 2009 Jan; 340(1):55-64. PubMed ID: 18983846
[TBL] [Abstract][Full Text] [Related]
13. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
[TBL] [Abstract][Full Text] [Related]
14. Fatigue in Multiple Sclerosis: Is it related to cytokines and hypothalamic-pituitary-adrenal axis?
Akcali A; Zengin F; Aksoy SN; Zengin O
Mult Scler Relat Disord; 2017 Jul; 15():37-41. PubMed ID: 28641771
[TBL] [Abstract][Full Text] [Related]
15. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
17. Humoral factors in ALS patients during disease progression.
Ehrhart J; Smith AJ; Kuzmin-Nichols N; Zesiewicz TA; Jahan I; Shytle RD; Kim SH; Sanberg CD; Vu TH; Gooch CL; Sanberg PR; Garbuzova-Davis S
J Neuroinflammation; 2015 Jun; 12():127. PubMed ID: 26126965
[TBL] [Abstract][Full Text] [Related]
18. Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Malekzadeh A; de Groot V; Beckerman H; van Oosten BW; Blankenstein MA; Teunissen C
Methods; 2012 Apr; 56(4):508-13. PubMed ID: 22465283
[TBL] [Abstract][Full Text] [Related]
19. Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.
Kallaur AP; Reiche EMV; Oliveira SR; Simão ANC; Pereira WLCJ; Alfieri DF; Flauzino T; Proença CM; Lozovoy MAB; Kaimen-Maciel DR; Maes M
Mol Neurobiol; 2017 Jan; 54(1):31-44. PubMed ID: 26732588
[TBL] [Abstract][Full Text] [Related]
20. Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
Shaygannejad V; Montazeri S; Jamshidian A; Tahani S; Gharagozloo M; Ashtari F; Vesal S; Hasheminia SJ; Dehghani L
Iran J Immunol; 2014 Jun; 11(2):134-8. PubMed ID: 24975970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
